Patent ID: 8563566

Claim:
A compound of formula IB where W and Z are, independently, CH or N; where R 1 and R 2 , are, independently, H, halogen, CH 2 F, CHF 2 , CF 3 , CF 2 CF 3 , C 1 -C 6 alkyl, C(═O)C 1 -C 6 alkyl, CH 2 C(═O)C 1 -C 6 alkyl, NH—C 1 -C 6 alkyl, NHC(═O)C 1 -C 6 alkyl, C(═O)N(CH 3 ) 2 , C(═O)N(Et) 2 , C(═O)NH—C 1 -C 6 alkyl, C(═O)OC 1 -C 6 alkyl, OC(═O)C 1 -C 6 alkyl, OC 1 -C 6 alkyl, SC 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, (CH 2 ) m C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkenyl, (CH 2 ) m C 3 -C 6 cycloalkenyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, Ar 1 , (CH 2 ) m Ar 1 , phenyl, pyridyl, pyrrolyl, (CH 2 ) m imidazolyl, (CH 2 ) m pyrazyl, furyl, thienyl, (CH 2 ) m oxazolyl, (CH 2 ) m isoxazolyl, (CH 2 ) m thiazolyl, (CH 2 ) m isothiazolyl, (CH 2 ) m phenyl, (CH 2 ) m pyrrolyl, (CH 2 ) m pyridyl, or (CH 2 ) m pyrimidyl, which cycloalkyl and said cycloalkenyl groups optionally contain one or two heteroatoms selected independently from O, N, and S, and which alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, imidazolyl, pyrazyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, phenyl, pyrrolyl, pyridyl, or pyrimidyl groups are optionally substituted with one or two groups selected, independently, from OH, halogen, cyano, methyl, ethyl, and trifluoromethyl, where m is zero, 1, or 2; or R 1 and R 2 , together with the ring carbon atoms to which they are attached, form a 5- or 6-member fused ring, which ring may be saturated, unsaturated, or aromatic, which optionally contains one or two heteroatoms selected independently from O, N, and S, and which is optionally substituted with halogen, CF 3 , or C 1 -C 3 alkyl; R′ is H, halogen, CF 3 , or C 1 -C 3 alkyl; R 3 and R 4 are, independently, H, NH 2 , (C 1 -C 3 alkyl)NH, CN, halogen, CF 3 , OCF 3 , OC 1 -C 3 alkyl, or C 1 -C 3 alkyl, all said C 1 -C 3 alkyl groups and said C 1 -C 6 alkyl groups optionally substituted with one or two groups selected, independently, from OH, halogen, C 1 -C 3 alkyl, OC 1 -C 3 alkyl, and trifluoromethyl; R 5 is C 1 -C 6 alkyl, (CHR 6 ), C 3 -C 6 cycloalkyl, (CHR 6 ) w CH 2 C 3 -C 6 cycloalkyl, CH 2 (CHR 6 ) w C 3 -C 6 cycloalkyl, CR 6 ═CH—C 3 -C 6 cycloalkyl, CH═CR 6 —C 3 -C 6 cycloalkyl, (CHR 6 ) w C 5 -C 6 cycloalkenyl, CH 2 (CHR 6 ) w C 5 -C 6 cycloalkenyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, Ar 1 , (CHR 6 ) w Ar 1 , CH 2 (CHR 6 ) w Ar 1 , or (CHR 6 ) w CH 2 Ar 1 , where w=0-3, Ar 1 is phenyl, pyridyl, furyl, thienyl, pyrrolyl, oxazolyl, thiazolyl, or imidazolyl, wherein said C 1 -C 6 alkyl group is optionally substituted with hydroxy, methoxy, methylthio, or halogen, and where said cycloalkyl and cycloalkenyl groups are optionally substituted with one or two groups selected, independently, from OH, halogen, cyano, methoxy, methyl, ethyl and trifluoromethyl; R 6 is hydrogen, methyl, halogen, or methoxy; or a pharmaceutically acceptable salt thereof.